Skip to Content
Contact Form Map & Directions Videos

Category: Defective Drugs

Spoliation and Sanctions

02/19/2014
Articles
BY

Spoliation of evidence has been defined by the courts as “the destruction or significant alteration of evidence, or the failure to preserve property for another’s use as evidence in pending or reasonably foreseeable litigation.” The concept behind this word defies one of the basic tenants in our legal system – […]

Read More

FDA Eyes Pradaxa Again

02/6/2014
Articles
BY

Despite all the company assurances that the anticoagulant Pradaxa is a superior alternative to warfarin, the Food and Drug Administration (FDA) plans to once again compare the two. Pradaxa was approved in 2010 but has since then brought a high complication rate to its users  – including dangerous and uncontrolled bleeding […]

Read More

FDA Fails in Many Drug and Device Reviews

01/29/2014
Defective Drugs
BY

A trio of studies published in the Journal of the American Medical Association (JAMA) finds that just because a drug or medical device makes it to market does not necessarily mean it’s been tested and is safe and effective beyond all doubt. According to three published reviews, the same standards […]

Read More

Novartis Denied U.S. Supreme Court Consideration

01/14/2014
Defective Drugs
BY

The U.S. Supreme Court has denied a request by drugmaker Novartis to revisit the issue of whether punitive damages can be awarded in product liability lawsuits. Claiming immunity under the Food and Drug Administration (FDA), Novartis claimed that the FDA preempts state tort law which does allow punitive damages when […]

Read More

Hear What Our Clients Have To Say

"Every question that I had was answered in mere minutes and the follow through that the staff, secretaries and attorneys had was superior. I have dealt with many, many firms that have all disappointed me and Searcy Denney was by far the most thorough - I highly recommend them!"
Posted By: Susan Baker